Neuropeptide Y gene polymorphisms and chronic kidney disease progression

Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials

(2021) Ajay Chaudhuri et al.   DIABETES OBESITY & METABOLISM

Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges

(2021) Carmine Zoccali et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A role for NPY-NPY2R signaling in albuminuric kidney disease

(2020) Abigail C. Lay et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

(2019) Kitty J. Jager et al.   KIDNEY INTERNATIONAL

Neuropeptide Y and chronic kidney disease progression: a cohort study

(2018) Carmine Zoccali et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

(2017) Adeera Levin et al.   LANCET

The MAURO study: baseline characteristics and compliance with guidelines targets

(2012) Daniela Leonardis et al.   JOURNAL OF NEPHROLOGY

Activation of NFAT Signaling in Podocytes Causes Glomerulosclerosis

(2010) Y. Wang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes

(2010) U. Jaakkola et al.   MICROVASCULAR RESEARCH

The effect of joint exposures: examining the presence of interaction

(2009) Renée de Mutsert et al.   KIDNEY INTERNATIONAL